- Report
- October 2023
- 88 Pages
Malaysia
From €3056EUR$3,500USD£2,646GBP
- Report
- October 2023
- 70 Pages
Canada
From €3056EUR$3,500USD£2,646GBP
- Report
- October 2023
- 83 Pages
Israel
From €3056EUR$3,500USD£2,646GBP
- Report
- October 2023
- 78 Pages
United States
From €3056EUR$3,500USD£2,646GBP
- Report
- October 2023
- 89 Pages
Malaysia
From €3056EUR$3,500USD£2,646GBP
- Report
- August 2023
- 75 Pages
Canada
From €3056EUR$3,500USD£2,646GBP
- Report
- August 2023
- 74 Pages
United States
From €3056EUR$3,500USD£2,646GBP
- Report
- April 2023
- 83 Pages
Europe
From €3493EUR$4,000USD£3,024GBP
From €3056EUR$3,500USD£2,646GBP
- Report
- February 2023
- 74 Pages
United States
From €3056EUR$3,500USD£2,646GBP
- Report
- March 2022
- 76 Pages
Saudi Arabia
From €3056EUR$3,500USD£2,646GBP
- Report
- January 2025
- 175 Pages
Global
From €3920EUR$4,490USD£3,394GBP
- Report
- January 2025
- 175 Pages
Global
From €3920EUR$4,490USD£3,394GBP
- Report
- January 2025
- 175 Pages
Global
From €3920EUR$4,490USD£3,394GBP
- Report
- January 2025
- 175 Pages
Global
From €3920EUR$4,490USD£3,394GBP
- Report
- January 2025
- 175 Pages
Global
From €3920EUR$4,490USD£3,394GBP
- Report
- January 2025
- 175 Pages
Global
From €3920EUR$4,490USD£3,394GBP
- Report
- January 2025
- 175 Pages
Global
From €3920EUR$4,490USD£3,394GBP
- Report
- January 2025
- 175 Pages
Global
From €3920EUR$4,490USD£3,394GBP
- Report
- September 2024
- 312 Pages
Global
From €4366EUR$5,000USD£3,780GBP

The Eye Disease market within the Optical industry is a rapidly growing sector, with a focus on providing treatments and solutions for a variety of eye conditions. This includes the diagnosis and management of conditions such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Companies in this market are developing innovative technologies to improve the accuracy and speed of diagnosis, as well as treatments to improve patient outcomes.
The Eye Disease market is also focused on providing solutions to improve patient access to care, such as telemedicine and remote monitoring. This is helping to reduce the burden on healthcare systems and improve patient outcomes.
Companies in the Eye Disease market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Essilor, Hoya, Johnson & Johnson Vision, Novartis, and Topcon. Show Less Read more